This announcement is for approval of a Phase 1 intravenous trial. I believe that the announcement we are all waiting on is for FDA approval of a Phase 2 intratumoral injection trial. Its a different trial process. We should IMO still get this announcement during April if the company provided the FDA with the updated information during the March quarter as it stated.